Cornerstone Planning Group’s iRadimed IRMD Stock Holding History

Cornerstone Planning Group’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.6K	Buy	155 +1	+0.6%	+$91	﹤0.01%	775
2026 Q1	$13.1K	Buy	154 +1	+0.7%	+$100	﹤0.01%	820
2025 Q4	$15K	Buy	153 +15	+11%	+$1.29K	﹤0.01%	673
2025 Q3	$10.5K	Buy	+138	New	+$9.2K	﹤0.01%	766
2025 Q2	–	Sell	-62	Closed	-$3.27K	–	1611
2025 Q1	$3.27K	Buy	+62	New	+$3.48K	﹤0.01%	847
2024 Q3	–	Sell	-15	Closed	-$664	–	1329
2024 Q2	$664	Buy	+15	New	+$638	﹤0.01%	1034

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cornerstone Planning Group's IRMD Position: Q2 2026 in Review

Cornerstone Planning Group increased its iRadimed (IRMD) stake by 0.65% in Q2 2026, buying an estimated $91 and bringing the position to 155 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #775.

Cornerstone Planning Group first reported a position in IRMD in Q2 2024 and has held it in 6 quarters since. The position peaked at $15K in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Cornerstone Planning Group held 155 shares of iRadimed worth $14.6K as of Q2 2026.
Cornerstone Planning Group bought 1 iRadimed share in Q2 2026, an estimated $91.
iRadimed made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #775 holding.
Cornerstone Planning Group first reported a position in iRadimed in Q2 2024 and has held it in 6 quarters since.
Cornerstone Planning Group's iRadimed position peaked at $15K in Q4 2025.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.